Unpackaged Medicaments in   China

Overview In February 2024 China's Unpackaged Medicaments exports accounted up to $70M and imports accounted up to $43.4M, resulting in a positive trade balance of $26.6M. Between February 2023 and February 2024 the exports of China's   Unpackaged Medicaments have decreased by $-15.6M (-18.2%) from $85.6M to $70M, while imports decreased by $-3.22M (-6.9%) from $46.6M to $43.4M.

Destinations In February 2024, Unpackaged Medicaments were exported mostly to India ($13M), Brazil ($5.95M), Turkey ($3.27M), United States ($3.25M), and South Korea ($3.08M), and were imported mostly from France ($24.6M), Italy ($6.03M), Sweden ($5.56M), Netherlands ($4.67M), and Belgium ($1.92M).

Growth In February 2024, the decrease in Unpackaged Medicaments's year-by-year exports was explained primarily by a decrease in exports to Hong Kong ($-5.93M or -60.3%), India ($-2.69M or -20%), and Pakistan ($-2.29M or -58.1%). In February 2024, the decrease in Unpackaged Medicaments's year-by-year imports was explained primarily by a decrease in imports from Sweden ($-3.77M or -68.4%), Belgium ($-3.27M or -87.4%), and Germany ($-1.08M or -33.5%).